معرفی
Professor Paul Scuffham is a leading health economist at Griffith University's School of MDP - Clinical Medicine. With over 450 scientific publications and 17,500 citations, he ranks in the top 1% of global scientists (Stanford-Elsevier). His work bridges economic evaluation with health policy translation, focusing on cost-benefit analysis, priority setting, and discrete choice experiments.
- Established the Centre for Applied Health Economics (CAHE)
- Former Director of the Menzies Health Institute Queensland (2019-2023)
- Chair of the ISPOR Asia Consortium (2022-2024)
- Associate Editor of Medical Decision Making Policy & Practice
His research spans comorbid conditions, health technology assessment, and applied economic methods, with recent projects on bariatric surgery prioritization frameworks and genetic testing cost-effectiveness in prostate cancer. He has led large-scale clinical trial economic evaluations, including a 45,000-participant health coaching study.
Key scientific awards include Fellow of the Australian Academy of Health and Medical Sciences (2016) and Vice-Chancellor's Award for Excellence of a Research Group (2016). As a supervisor, he has mentored over 20 doctoral students in health economics and translational research.
Grants include NHMRC funding for AI in medical imaging (2025-2027) and MRFF projects on cardiovascular disease management. His work on public preferences via citizen juries and discrete choice experiments has shaped policy frameworks for medicinal cannabis and healthcare resource allocation.
